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Abstract
The presence of apoptosis has been investigated in the interface membranes collected during revision surgery of loosened total hip
joint arthroplasty (THAs). Terminal deoxyrobonucleotidyl transferase (TdT) assay for apoptotic DNA fragmentation
quantification revealed a statistically significant presence of apoptosis in aseptic samples, obtained from both cementless
(2.3770.6%) and cemented (12.0171%) prosthesis compared to septic samples where apoptosis was almost absent. Activated
caspase-8 immunostaining was almost undetectable in septic samples, while in the aseptic samples active caspase-8 was present
weakly in the cementless samples (1.3570.22%) and strongly in the cemented ones (9.070.40%). The caspase-8 cytoplasmatic
staining allowed the morphological recognition of positive cells both as fibroblast-like and immunocompetent cells. In aseptic
cemented samples fibroblast-like cells were the most represented subpopulation in the caspase-8 positive population scored (76.6%)
compared to the immunocompetent cells (23.4%).
Caspase-8 activation is an upstream event in the apoptotic pathway triggered by the activation of cytokines receptors such as
TNF-a receptor 1 (TNFR-1), and the presence of caspase-8 activation in fibroblast-like cells in the aseptic interface membranes of
THAs suggests a possible TNF-a dependent apoptosis.
r 2003 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Aseptic loosening of orthopedic implants used in joint
replacement results from bone loss that occurs through
the resorptive activity of inflammatory cells activated by
the presence of wear particles [1]. Inflammatory cells,
mainly macrophages, lymphocytes and mast cells have
been observed in this inflammatory reaction at the
interface membrane and it has been demonstrated that
in vitro polyethyene, ceramics and metal wear particles
induce macrophage apoptosis [2,3]. Apoptosis has been
observed in the periprosthetic site and it has been
interpreted as a sign of resolution of inflammation [4].
Apoptosis is a physiological, gene-directed form of
mechanism of programmed cell death aimed to the
maintenance of tissue homeostasis [5]. Apoptosis plays a
crucial role in modulating tissue growth during embryo-
nic development and cell turnover in adult life,
particularly in immunological and hormone-dependent
systems [6]. Cells appear to initiate their own apoptotic
death through the activation of endogenous proteases
called caspases. Their activation results in cytoskeletal
disruption, cell shrinkage, and membrane blebbing.
Apoptosis also involves characteristic changes within the
nucleus that undergoes condensation and DNA is
degraded into DNA fragments the size of oligonucleo-
somes [7]. The presence of apoptotic cell death has been
detected in interface membrane the fibrous tissue between
implant and bone, of aseptically loose total hip arthro-
plasties (THAs) suggesting that apoptosis-related events
are indeed associated with periprosthetic osteolysis [8].
In order to investigate the presence and the mechan-
isms of apoptosis at the periprosthetic sites, apoptotic
cells have been quantified using both terminal deoxyr-
obonucleotidyl transferase (TdT) assay for DNA
fragmentation quantification and active caspase-8 im-
munostaining in implant tissues collected during revi-
sion surgery of loosened hip joint prostheses.
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2. Materials and methods
2.1. Specimen collection
Twelve specimens of bone implant interface mem-
brane from cementless and cemented total hip replace-
ment (THAs) were taken at the time of revision surgery
for septic (cemented, n ¼ 2; cementless=2) and aseptic
(cemented, n ¼ 4; cementless, n ¼ 4) loosening at the
CTO, Dept. of Orthopedics, Traumatology and Occu-
pational Medicine, University of Turin, Italy.
2.2. Tissue processing
Each specimen was washed in cold phosphate-
buffered saline (PBS) and fixed in 10% buffered
formalin. Specimens were then dehydrated through
ascending series of ethanol, cleared in xylen and
embedded in semi-synthetic paraffin (Sherwood Medical
Co. St. Louis, MO, USA).
Entire paraffin blocks were cut serially with a rotatory
microtome (Leica-Jung, Germany) in consecutive 5 mm
thick sections, and subdivided for morphological
analysis in groups of ten section each.
2.3. TUNEL technique
For in situ TUNEL technique, an Apoptags kit
(Intergen Company, New York, USA) was used. Five
sections for sample(s) were incubated with proteinase-K
for 15min at room temperature, washed with phos-
phate-buffered saline (PBS) (pH 7.2–7.4) and quenched
in 1% H2O2 in PBS for 5min followed by three washes
in PBS. They were then incubated with equilibrating
buffer for 15 s. After draining off excess buffer, sections
were treated with 54 ml of terminal deoxyrobonucleoti-
dyl transferase (TdT) enzyme for 1 h at 37C, labelled
nick-end tail with digoxigenin-dNTP, incubated for
10min at room temperature in the stop-wash buffer and
incubated for 30min at room temperature with anti-
digoxigenin peroxidase conjugate antibody. At the end of
incubation sections were washed again with PBS and
exposed to diaminobenzidine (DAB) solution to developed
reaction product. After washing in distilled water, sections
were counter-stained with Methyl Green, dehydrated and
mounted in a semi-synthetic mounting medium.
The percentage of apoptotic cells per section was
determined by the ratio of TUNEL positive nuclei/total
nuclei number. Ten microscopic fields of 50–200 nuclei
(400 magnification) on five different sections were
analyzed for each sample.
2.4. Caspase-8 immunohistochemistry
Five sections for each sample were processed for
caspase-8 immunohistochemistry by exposing them to
rabbit monoclonal antibody raised against activated
caspase-8 (Upstate biotech, NY, USA) at a concentra-
tion of 1 mg/ml. The section were hydrated, and
incubated in a specific serum for 1 h at room tempera-
ture. Primary antibody incubation was done overnight
in a humid chamber at 4C. The excess of unbound
antibody was removed by washing sections twice in the
buffer solution. The product of immunoreaction was
revealed by incubating sections with anti-rabbit second-
ary antibody complexed with avidin-biotin system and
evidenced by DAB reaction (ABC Staining System kit,
Santa Cruz, CA, USA; sc-2018). Control sections were
processed as above, but using a non-immune mouse IgG
instead of primary antibody, or by omitting the primary
antibody from incubation medium. In these conditions
no specific immunostaining was observed.
The percentage of caspase positive cells per section
was determined by the ratio of caspase positive cell/total
cell number. Caspase positive cells were also identified
on the basis of morphology as fibroblast-like cells (cell
presenting elongated body cell profile resident between
collagen fibers bundles) or immunocompetent cells (cell
with a small round body). Ten microscopic fields of 50–
200 nuclei (400 magnification) on five different
sections were analyzed for each sample.
2.5. Data analysis
Means of different parameters investigated were
calculated from single sample data, and group means7
S.E.M, were then obtained from single sample values.
Statistical analysis of variance (ANOVA) was used; the
significance of differences between means was assessed
by Newman–Keuls multiple range test, taking po0:05
as the minimum level of significance.
3. Results
3.1. TdT analysis of apoptosis
TUNEL reaction was localized in cell nuclei present
in the perimplantal tissue obtained from failed implants,
both aseptic and septic (Fig. 1). In the septic samples
very few apoptotic cells were counted and the percen-
tage of TdT positive cells observed was 1.1270.3% and
0.870.4% for cementless (SNC) and cemented (SC)
samples respectively. In the aseptic samples the number
of apoptotic cells raised to a percentage of 2.3770.6%
(po0:05) and 12.0171% (po0:001) respectively in
cementless (ANC) and cemented (AC) samples. This
increase in the number of TdT-positive cells in the
aseptic samples (Fig. 2) was particularly evident in the
samples from cemented prosthesis (Fig. 2B) compared
to the ones from cementless samples (Fig. 2A).
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3.2. Caspase-8 activation in fibroblast
The caspase-8 positivity profile observed for the four
categories of samples was similar to the one obtained for
TdT positivity (Fig. 3).
In fact, the positivity observed in the septic samples
was almost undetectable (0.770.21% and 0.570.23%
for SNC and SC samples respectively) (Fig. 3), while in
the aseptic samples caspase-8 was active weakly in the
cementless samples (ANC) (1.3570.22, po0:05) and
strongly in the cemented ones (AC) (9.070.40%,
po0:001). As shown in Fig. 4A and B, the caspase-8
staining in the ANC (A) and AC (B) samples was
dispersed in the cell cytoplasm allowing a clear
recognition of the cell shape. Caspase-8 positive
cells have been divided in fibroblast-like (elongated
cell body) and immunocompetent (round cell body)
cells (Fig. 4C and D) on the basis of cell shape. As
shown in Fig. 5 the majority of the caspase–8 positive
cells scored both in ANC and AC were fibroblast-like
cells as observed on the basis of their morphology
(76.6% of caspase-8 positive cells). Moreover caspase-8
positive fibroblast-like cells accounted for the
16.472.1% of the total fibroblast-like population (data
not shown).
4. Discussion
Loosening of total hip prosthesis is a critical
phenomenon in the treatment of total hip arthroplasty
and it can be induced by a chronic infection or
aseptically by both mechanical stress and local host
response to wear debris of high density polyethylene,
metals and bone cement [9]. Studies of the retrieved
periprosthetic membrane, the fibrous tissue formed at
the bone–implant interface, have identified the presence
of apoptotic cells in this neoformed tissue. These studies
have been performed mainly in membranes derived from
aseptic loosening and apoptotic cells have not been
clearly phenotypized [4,8,10]. Moreover the apoptosis
triggering mechanism and the consequences of the
phenomenon in the periprosthetic tissue have not been
fully elucidated.
In our study, we observed that apoptosis, identified
on the basis of late phase of DNA fragmentation, is
almost undetectable in samples from septic loosening,
while appears significant in samples from aseptic
loosening in accordance with previous findings that
observed a necrotic instead of apoptotic evolution of
periprosthetic tissue in the presence of chronic infection
[9].
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Fig. 1. Apoptosis in interface membrane of failed THAs. Results for
all specimens are expressed as the percentage of positive labelling for
TUNEL staining. SNC=septic cementless, SC=septic cemented,
ANC=aseptic cementless, AC=aseptic cemented. *po0:05;
**po0:001:
(A) (B)
Fig. 2. In situ labelling of apoptosis-induced strand breaks in interface membranes of aseptically failed THAs. Relatively few positively stained cells
were observed in cementless THA samples (A) compared to the cemented ones (B). Bar scale=65 mm.
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Fig. 3. Caspase-8 activation in interface of failed THA. The figure
presents the summary of results for all specimens, expressed as the
percentage of positive labelling for anti-activated Caspase-8 staining.
SNC=septic cementless, SC=septic cemented, ANC=aseptic cement-
less, AC=aseptic cemented. *po0:05; **po0:001:
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Apoptosis in periprosthetic tissues seems to occur in
cemented and cementless prosthesis without remarkable
differences [4]. On the contrary in our samples the
presence of cement increased the percentage of TdT
positive cells. In fact bone cements have been shown to
induce in vitro apoptosis in osteoblast-like and HL-60
cells [11,12]. These observations suggest that the
apoptosis observed in the cementless samples could be
mainly a ‘‘physiological’’ apoptosis occurring during the
normal tissue turnover [5].
In the apoptotic pathways, caspase-8 acts as initiator
of caspases proteolytic cascade leading to cell death [13].
Caspase-8 plays a key role in apoptosis triggered by
death receptor such as Fas, TNFR-1 and DR3 [14].
Moreover caspase-8 is involved in tumor cell death
induced by chemotherapeutic drugs [15]. In the peri-
prosthetic membranes high levels of pro-inflammatory
cytokines such as IL-1b; IL-6 and TNF-a [16,17] are
produced mainly by monocytes/macrophages [18] after
contact with debris. Cytokines play a key role in the
tissue response to the implant [19] and induce pro-
apoptotic signals through cell receptor activation [18].
Caspase-8 immunohistochemistry was performed
using a monoclonal antibody raised against the active
form of enzyme in order to confirm the presence of
apoptosis and to investigate the possible triggering
mechanism of the phenomenon.
The caspase-8 positivity observed resembled the TdT
positivity previously scored and also in this case AC
samples presented a higher percentage of positive cells
compared to all the other samples. Moreover, we
distinguished, on a morphological basis, caspase-8
positive fibroblast-like and immunocompetent cells.
The observed fibroblast apoptosis has not been de-
scribed previously. In fact apoptosis in the perimplantal
tissue has been described mainly as an inflammation
resolutive mechanism [4]. Induction of apoptosis in
fibroblast could be due to both cell activation and
mechanical loading. In fact, it has been demonstrated
that contraction of collagen gel induces fibroblast
apoptosis through an integrin b1-dependent mechanism
[20] and cyclic mechanical pressure induced cytokines
production in human monocytes/macrophages in a
synergistic action with debris [21]. Among cytokines,
TNF-a secreted by active macrophages [22] acts
modulating the fibroblast proliferation [23], inducing
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Fig. 4. In situ labelling for caspase-8 activation in interface membranes of aseptically failed THAs. Relatively few positively stained cells were
observed in cementless THA samples (A) compared to the cemented ones (B). In samples treated for anti-activated caspase-8 staining (cytoplasmatic
staining) it was possible to observe both fibroblast-like cells with an elongated body (C) and immunocompetent cells with a small round body
(arrows) (D). Bar scale=(A,B) 45 mm; (C,D)15mm.
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Fig. 5. Caspase-8 activation in interface membrane of failed THA.
The figure presents the summary of results for all specimens, expressed
as the percentage of fibroblast-like (black bar) and immunocompetent
(white bar) caspase-8 positive cells scored on the basis of their
morphology. SNC=septic cementless, SC=septic cemented, ANC=
aseptic cementless, AC=aseptic cemented. *po0:05; ** po0:001:
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apoptosis [24] and it is involved in the pathogenesis of
fibrotic diseases [25]. Furthermore TNF-a is directly
involved in periprosthetic osteolysis [26] and an anti-
TNF-a therapy has been proposed as a clinical inter-
vention for periprosthetic osteolysis [27]. Moreover
TNF-a activates the caspase-8 pathway through the
activation of TNFR-1 [28]. On the basis of our results,
we hypothesize that TNF-a is responsible for the
apoptosis observed in the fibroblast-like population in
the periprosthetic membrane, although TNF-a levels
modulation by bone cement is controversial [17,29].
In this scenario the fibroblast apoptosis could be
considered as a side effect of inflammation leading to the
end of the fibrotic reaction. The observed quantitative
difference in the percentage of TdT-positive cells and
caspase-8 positive cells could be accounted for the
different temporal occurrence of the two phenomena
during apoptosis [30]. In fact, caspase-8 activation is an
early upstream event in the apoptosis and caspase-8
positive cells could be negative for TdT with a DNA still
intact. On the other hand we could not exclude
completely that caspase-8 activation is the only trigger
of apoptosis in the periprosthetic tissues examined.
5. Conclusions
In conclusion, the fibroblast caspase-8 activation
observed in the periprosthetic tissue from cemented
prosthesis is a new element in the complex series of
events occurring during aseptic loosening. The caspase-8
mediated apoptosis could be induced by high levels of
TNF-a in the cemented prosthesis–tissue interface
suggesting another effect of this cytokine in the aseptic
loosening.
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